A visual indicator for inhalation from a valved holding chamber (VHC) is an aid in delivery of inhaled medication to infants and small children via facemask

J. Mitchell, C. Doyle, R. Ali, V. Avvakoumova, M. Nagel, R. Sharpe (London, Canada)

Source: Annual Congress 2009 - New aspects of inhalation therapy
Session: New aspects of inhalation therapy
Session type: Thematic Poster Session
Number: 2044
Disease area: Paediatric lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Mitchell, C. Doyle, R. Ali, V. Avvakoumova, M. Nagel, R. Sharpe (London, Canada). A visual indicator for inhalation from a valved holding chamber (VHC) is an aid in delivery of inhaled medication to infants and small children via facemask. Eur Respir J 2009; 34: Suppl. 53, 2044

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Medication delivery via infant and child valved holding chambers (VHCs) with facemask is aided with inhalation flow indicator
Source: Annual Congress 2008 - Diagnosing, monitoring and treating respiratory diseases in primary care
Year: 2008


In vitro testing of an improved collapsible valved holding chamber (CHC) with a pressurized metered-dose inhaler delivered bronchodilator, simulating an adult mechanically ventilated patient
Source: Annual Congress 2010 - Treatment options for asthma
Year: 2010


In vitro delivery of an HFA-based corticosteroid by pediatric and adult valved holding chambers (VHC): effect of inhalation flow rate
Source: Eur Respir J 2002; 20: Suppl. 38, 500s
Year: 2002

Impact of inhalation delay on medication delivery from a salbutamol HFA pressurized metered dose inhaler used with and without a new prototype portable valved holding chamber
Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies
Year: 2019

Delivery of medication via a novel non-electrostatic valved holding chamber (VHC) for infant use depends on the number of inhalations
Source: Eur Respir J 2006; 28: Suppl. 50, 713s
Year: 2006

Feedback during treatment results in increased adherence when using a pressurized metered dose inhaler with valved holding chamber in paediatric patients with asthma
Source: Annual Congress 2008 - Clinical aspects of asthma in school-aged children
Year: 2008

Medication delivery testing of valved holding chambers (VHCs) with facemask for infant use by means of a model infant face
Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques
Year: 2016

Valved holding chamber (VHC) angle can affect pressurized netered-dose inhaler (pMDI) medication delivery efficiency
Source: International Congress 2018 – Determinants and monitoring of asthma control
Year: 2018




Antistatic treatment and the amount of salbutamol actuated have variable effect on drug delivery of six different valved holding chambers (VHC)
Source: International Congress 2019 – Severe acute asthma and troublesome wheezing
Year: 2019

In vitro performance of an improved collapsible holding chamber (CHC) for the delivery of bronchodilators to patients receiving mechanical ventilation
Source: Annual Congress 2011 - Mechanical ventilation and lung injury: new advances
Year: 2011

New anti-static youth valved holding chamber (VHC) can be used out-of-package and deliver β2-agonist medication effectively
Source: Annual Congress 2009 - New aspects of inhalation therapy
Year: 2009


Laboratory assessment of drug delivery of Beclomethasone/Formoterol metered dose inhaler (MDI) with a new valved holding chamber (VHC) designed specifically for 'on-the-go' use.
Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19
Year: 2021


Impact of inspiratory delay and valved holding chamber (VHC) material on drug delivery
Source: Eur Respir J 2001; 18: Suppl. 33, 494s
Year: 2001

Breath-by-breath delivered dose comparison from three anti-static valved holding chambers with facemasks under simulated pediatric breathing conditions
Source: Annual Congress 2011 - Treating childhood asthma
Year: 2011

In vitro evaluation of a novel ventilation chamber (VC) for delivery of aerosolized medication to the mechanically ventilated premature infant
Source: Annual Congress 2009 - New aspects of inhalation therapy
Year: 2009


Priming of a non-conducting valved holding chamber (VHC) is formulation dependent and may result in inconsistent medication delivery
Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology
Year: 2007


In vitro delivery of budesonide from 10 jet nebulisers using a child breathing pattern
Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence
Year: 2007


Delivery of an HFA-formulated bronchodilator to the mechanically ventilated adult patient via holding chamber: laboratory simulation
Source: Eur Respir J 2003; 22: Suppl. 45, 473s
Year: 2003

The impact of different valved holding chambers (VHCs) on lung drug delivery: using functional respiratory imaging (FRI) and a single metered dose inhaler (MDI) type
Source: Virtual Congress 2020 – Diagnosis and management of airways disease in primary care
Year: 2020




In vitro equivalence exists for infant non-conducting (NC) and anti-static (AS) valved holding chambers (VHC) from the same family of add on devices used with pressurized metered dose inhalers (pMDIs) provided pre-conditioning of the non-conducting VHCs is undertaken
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I
Year: 2010